NFKB1 and colitis: Cheon et al. (2018), Choi et al. (2018), Hwang et al. (2018), Kim et al. (2017b), Lee et al. (2016) and Lim et al. (2008) all have reported that TUS blocks NF-κB pathway in exogenous-agent-induced colitis mice, airway epithelial cells, focal cerebral ischemia rats, septic mice, skin inflammation mice, and BV-2 microglial cells by attenuating the nuclear translocation of p65 subunit and the phosphorylation and (or) degradation of IκBα. Among them, Choi et al. (2018) have also observed the alleviation of phosphorylated IKK complex.